尽管分析师的评级下调, 但伊利莉公司同意以78亿美元收购Centessa股票后, Centessa stock surged after Eli Lilly agreed to acquire it for $7.8 billion, despite analyst downgrades.

尽管该公司股价最近在伊利莉的收购协议中升至52周高,但其Q1财报出现不佳后面临着分析师评级的混杂. Centessa Pharmaceuticals (CNTA) faces mixed analyst ratings following a Q1 earnings miss, though the stock recently surged to a 52-week high on news of Eli Lilly’s agreement to acquire the company for up to $7.8 billion. 尽管有潜在的交易, 但几家公司将股票降级为"持有", Despite the potential deal, several firms downgraded the stock to "hold," and shareholder lawsuits have been filed questioning the transaction's fairness.